FindTrial
Sign In

Immune monitoring of cytomegalovirus infection after simultaneous pancreas kidney transplantation

Immune monitoring of cytomegalovirus infection after simultaneous pancreas kidney transplantation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100048617
Enrollment
Unknown
Registered
2021-07-11
Start date
2021-07-11
Completion date
Unknown
Last updated
2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cytomegalovirus infection

Interventions

Observation group:none

Sponsors

the Second Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients aged 18-65; 2. Patients with end-stage renal disease combined with diabetes mellitus who underwent combined pancreas-kidney transplantation; 3. Those who voluntarily joined the trial and signed the informed consent form.

Exclusion criteria

Exclusion criteria: No.

Design outcomes

Primary

MeasureTime frame
CD8+ T cell;—

Countries

China

Contacts

Public ContactChen Zheng

The Second Affiliated Hospital of Guangzhou Medical University

316964994@qq.com+86 13808896300

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026